Literature DB >> 17932703

Treosulfan impedes the migration of immunocompetent cells.

T Kopadze, T Dehmel, H A Mylius, H-P Hartung, H Wiendl, B C Kieseier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17932703     DOI： 10.1007/s00415-007-0552-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

Review 1.  Immunopathogenesis and immunotherapy of multiple sclerosis.

Authors:  Bernhard Hemmer; Stefan Nessler; Dun Zhou; Bernd Kieseier; Hans-Peter Hartung
Journal:  Nat Clin Pract Neurol       Date:  2006-04

Review 2.  Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.

Authors:  Heinz Wiendl; Bernd C Kieseier
Journal:  Expert Opin Investig Drugs       Date:  2003-04       Impact factor: 6.206

3.  Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis.

Authors:  Tea Kopadze; Thomas Dehmel; Hans-Peter Hartung; Olaf Stüve; Bernd C Kieseier
Journal:  Arch Neurol       Date:  2006-11

4.  Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

Authors:  O Stüve; N P Dooley; J H Uhm; J P Antel; G S Francis; G Williams; V W Yong
Journal:  Ann Neurol       Date:  1996-12       Impact factor: 10.422

5.  Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.

Authors:  Robert Weissert; Heinz Wiendl; Heike Pfrommer; Maria K Storch; Bettina Schreiner; Silvia Barth; Thomas Seifert; Arthur Melms; Johannes Dichgans; Michael Weller
Journal:  J Neuroimmunol       Date:  2003-11       Impact factor: 3.478

6.  Treatment of active secondary progressive multiple sclerosis with treosulfan.

Authors:  Heinz Wiendl; Bernd C Kieseier; Robert Weissert; Heidrun A Mylius; Uwe Pichlmeier; Hans-Peter Hartung; Arthur Melms; Wilhelm Kuker; Michael Weller
Journal:  J Neurol       Date:  2007-04-20       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.